VJNeurology is committed to improving our service to you

Share this video  

VJNeurology is committed to improving our service to you

CONy 2022 | The emergence of COVID-19-induced parkinsonism

Angelo Antonini, MD, PhD, University of Padua, Padua, Italy, discusses whether COVID-19 infection negatively impacted patients with Parkinson’s disease more than the general populace. Despite studies suggesting that COVID-19 can induce neurodegeneration in people with an underlying dopaminergic deficit or an existing inflammatory condition, Prof. Antonini highlights how COVID-19 cannot enter the brain stem and central nervous system and the number of new cases of Parkinson’s disease has additionally not increased during the pandemic, suggesting the virus has not made in impact in inducing parkinsonism. This interview was conducted during the 2022 World Congress on Controversies in Neurology (CONy) meeting.